Multiple protein partners

The term Multiple protein partners does not refer to a specific, individual therapeutic target such as a receptor, enzyme, or ion channel. Instead, it is a collective designation often used in pharmacological and biochemical databases to describe a scenario where a drug or molecule interacts with a variety of different proteins to exert its biological effects. This classification denotes polypharmacology, where the therapeutic outcome is driven by the modulation of several distinct molecular entities simultaneously rather than a single gene product. Because it represents a group of targets rather than a specific protein, it lacks a unique UniProt identifier, conserved biological functions, or a singular role in disease pathology. For biotech analysts, this term signifies a lack of molecular specificity, which can be a deliberate strategy in the development of multi-kinase inhibitors but also presents significant risks regarding off-target toxicity and complex safety profiles.

Other names

Multi-targetPolypharmacological targetsNon-specific protein bindingMultiple targets

Non-specific or multi-target interaction